1887

Abstract

Theiler's murine encephalomyelitis virus (TMEV or Theiler's virus) is a neurotropic picornavirus that can persist lifelong in the central nervous system of infected mice, causing a chronic inflammatory demyelinating disease. The leader (L) protein of the virus is an important determinant of viral persistence and has been shown to inhibit transcription of type I interferon (IFN) genes and to cause nucleocytoplasmic redistribution of host proteins. In this study, it was shown that expression of the L protein shuts off synthesis of the reporter proteins green fluorescent protein and firefly luciferase, suggesting that it induces a global shut-off of host protein expression. The L protein did not inhibit transcription or translation of the reporter genes, but blocked cellular mRNA export from the nucleus. This activity correlated with the phosphorylation of nucleoporin 98 (Nup98), an essential component of the nuclear pore complex. In contrast, the data confirmed that the L protein inhibited IFN expression at the transcriptional level, and showed that transcription of other chemokine or cytokine genes was affected by the L protein. This transcriptional inhibition correlated with inhibition of interferon regulatory factor 3 (IRF-3) dimerization. Whether inhibition of IRF-3 dimerization and dysfunction of the nuclear pore complex are related phenomena remains an open question. , IFN antagonism appears to be an important role of the L protein early in infection, as a virus bearing a mutation in the zinc finger of the L protein replicated as efficiently as the wild-type virus in type I IFN receptor-deficient mice, but had impaired fitness in IFN-competent mice.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.005678-0
2009-01-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/1/177.html?itemId=/content/journal/jgv/10.1099/vir.0.005678-0&mimeType=html&fmt=ahah

References

  1. Baida, G., Popko, B., Wollmann, R. L., Stavrou, S., Lin, W., Tretiakova, M., Krausz, T. N. & Roos, R. P. ( 2008; ). A subgenomic segment of Theiler's murine encephalomyelitis virus RNA causes demyelination. J Virol 82, 5879–5886.[CrossRef]
    [Google Scholar]
  2. Blevins, M. B., Smith, A. M., Phillips, E. M. & Powers, M. A. ( 2003; ). Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP. J Biol Chem 278, 20979–20988.[CrossRef]
    [Google Scholar]
  3. Brahic, M., Bureau, J. F. & Michiels, T. ( 2005; ). The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol 59, 279–298.[CrossRef]
    [Google Scholar]
  4. Chakraborty, P., Satterly, N. & Fontoura, B. M. ( 2006; ). Nuclear export assays for poly(A) RNAs. Methods 39, 363–369.[CrossRef]
    [Google Scholar]
  5. Chen, H. H., Kong, W. P. & Roos, R. P. ( 1995; ). The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol 69, 8076–8078.
    [Google Scholar]
  6. Daniels, J. B., Pappenheimer, A. M. & Richardson, S. ( 1952; ). Observations on encephalomyelitis of mice (DA strain). J Exp Med 96, 517–530.[CrossRef]
    [Google Scholar]
  7. Delhaye, S., van Pesch, V. & Michiels, T. ( 2004; ). The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol 78, 4357–4362.[CrossRef]
    [Google Scholar]
  8. Delhaye, S., Paul, S., Blakqori, G., Minet, M., Weber, F., Staeheli, P. & Michiels, T. ( 2006; ). Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 103, 7835–7840.[CrossRef]
    [Google Scholar]
  9. Faria, P. A., Chakraborty, P., Levay, A., Barber, G. N., Ezelle, H. J., Enninga, J., Arana, C., van Deursen, J. & Fontoura, B. M. ( 2005; ). VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell 17, 93–102.[CrossRef]
    [Google Scholar]
  10. Fiette, L., Aubert, C., Muller, U., Huang, S., Aguet, M., Brahic, M. & Bureau, J. F. ( 1995; ). Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J Exp Med 181, 2069–2076.[CrossRef]
    [Google Scholar]
  11. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S. M. & Maniatis, T. ( 2003; ). IKKϵ and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491–496.
    [Google Scholar]
  12. Ghadge, G. D., Ma, L., Sato, S., Kim, J. & Roos, R. P. ( 1998; ). A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol 72, 8605–8612.
    [Google Scholar]
  13. Hato, S. V., Ricour, C., Schulte, B. M., Lanke, K. H., de Bruijni, M., Zoll, J., Melchers, W. J., Michiels, T. & van Kuppeveld, F. J. ( 2007; ). The mengovirus leader protein blocks interferon-α/β gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol 9, 2921–2930.[CrossRef]
    [Google Scholar]
  14. Her, L. S., Lund, E. & Dahlberg, J. E. ( 1997; ). Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276, 1845–1848.[CrossRef]
    [Google Scholar]
  15. Jnaoui, K. & Michiels, T. ( 1998; ). Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence. Virology 244, 397–404.[CrossRef]
    [Google Scholar]
  16. Kong, W. P. & Roos, R. P. ( 1991; ). Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol 65, 3395–3399.
    [Google Scholar]
  17. Kong, W. P., Ghadge, G. D. & Roos, R. P. ( 1994; ). Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A 91, 1796–1800.[CrossRef]
    [Google Scholar]
  18. Kramer, M., Schulte, B. M., Toonen, L. W., Barral, P. M., Fisher, P. B., Lanke, K. H., Galama, J. M., van Kuppeveld, F. J. & Adema, G. J. ( 2008; ). Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells. J Virol 82, 2930–2937.[CrossRef]
    [Google Scholar]
  19. Lidsky, P. V., Hato, S., Bardina, M. V., Aminev, A. G., Palmenberg, A. C., Sheval, E. V., Polyakov, V. Y., van Kuppeveld, F. J. & Agol, V. I. ( 2006; ). Nucleocytoplasmic traffic disorder induced by cardioviruses. J Virol 80, 2705–2717.[CrossRef]
    [Google Scholar]
  20. Lin, R., Heylbroeck, C., Genin, P., Pitha, P. M. & Hiscott, J. ( 1999a; ). Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 19, 959–966.
    [Google Scholar]
  21. Lin, R., Mamane, Y. & Hiscott, J. ( 1999b; ). Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19, 2465–2474.
    [Google Scholar]
  22. McAllister, A., Tangy, F., Aubert, C. & Brahic, M. ( 1989; ). Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb Pathog 7, 381–388.[CrossRef]
    [Google Scholar]
  23. Michiels, T., Dejong, V., Rodrigus, R. & Shaw-Jackson, C. ( 1997; ). Protein 2A is not required for Theiler's virus replication. J Virol 71, 9549–9556.
    [Google Scholar]
  24. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. & Aguet, M. ( 1994; ). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921.[CrossRef]
    [Google Scholar]
  25. Overbergh, L., Giulietti, A., Valckx, D., Decallonne, R., Bouillon, R. & Mathieu, C. ( 2003; ). The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14, 33–43.
    [Google Scholar]
  26. Panne, D., Maniatis, T. & Harrison, S. C. ( 2007; ). An atomic model of the interferon-β enhanceosome. Cell 129, 1111–1123.[CrossRef]
    [Google Scholar]
  27. Park, N., Katikaneni, P., Skern, T. & Gustin, K. E. ( 2008; ). Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J Virol 82, 1647–1655.[CrossRef]
    [Google Scholar]
  28. Paul, S. & Michiels, T. ( 2006; ). Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol 87, 1237–1246.[CrossRef]
    [Google Scholar]
  29. Petro, T. M. ( 2005; ). ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-β in Theiler's virus-infected RAW264.7 cells. Immunol Lett 97, 47–53.[CrossRef]
    [Google Scholar]
  30. Porter, F. W., Bochkov, Y. A., Albee, A. J., Wiese, C. & Palmenberg, A. C. ( 2006; ). A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc Natl Acad Sci U S A 103, 12417–12422.[CrossRef]
    [Google Scholar]
  31. Powers, M. A., Forbes, D. J., Dahlberg, J. E. & Lund, E. ( 1997; ). The vertebrate GLFG nucleoporin, Nup98, is an essential component of multiple RNA export pathways. J Cell Biol 136, 241–250.[CrossRef]
    [Google Scholar]
  32. Pritchard, C. E., Fornerod, M., Kasper, L. H. & van Deursen, J. M. ( 1999; ). RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains. J Cell Biol 145, 237–254.[CrossRef]
    [Google Scholar]
  33. Rodriguez, M. S., Dargemont, C. & Stutz, F. ( 2004; ). Nuclear export of RNA. Biol Cell 96, 639–655.[CrossRef]
    [Google Scholar]
  34. Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J. & Pitha, P. M. ( 1998; ). Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem 273, 2714–2720.[CrossRef]
    [Google Scholar]
  35. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R. & Hiscott, J. ( 2003; ). Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151.[CrossRef]
    [Google Scholar]
  36. Shaw-Jackson, C. & Michiels, T. ( 1999; ). Absence of internal ribosome entry site-mediated tissue specificity in the translation of a bicistronic transgene. J Virol 73, 2729–2738.
    [Google Scholar]
  37. Sommereyns, C., Paul, S., Staeheli, P. & Michiels, T. ( 2008; ). IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4, e1000017 [CrossRef]
    [Google Scholar]
  38. Theiler, M. & Gard, S. ( 1940; ). Encephalomyelitis of mice. I. Characteristics and pathogenesis of the virus. J Exp Med 72, 49–67.[CrossRef]
    [Google Scholar]
  39. van Eyll, O. & Michiels, T. ( 2002; ). Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J Virol 76, 10665–10673.[CrossRef]
    [Google Scholar]
  40. van Pesch, V. & Michiels, T. ( 2003; ). Characterization of interferon-α13, a novel constitutive murine interferon-α subtype. J Biol Chem 278, 46321–46328.[CrossRef]
    [Google Scholar]
  41. van Pesch, V., van Eyll, O. & Michiels, T. ( 2001; ). The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 75, 7811–7817.[CrossRef]
    [Google Scholar]
  42. van Pesch, V., Lanaya, H., Renauld, J. C. & Michiels, T. ( 2004; ). Characterization of the murine alpha interferon gene family. J Virol 78, 8219–8228.[CrossRef]
    [Google Scholar]
  43. Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E. & Fujita, T. ( 1998; ). Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17, 1087–1095.[CrossRef]
    [Google Scholar]
  44. Zoll, J., Galama, J. M., van Kuppeveld, F. J. & Melchers, W. J. ( 1996; ). Mengovirus leader is involved in the inhibition of host cell protein synthesis. J Virol 70, 4948–4952.
    [Google Scholar]
  45. Zoll, J., Melchers, W. J., Galama, J. M. & van Kuppeveld, F. J. ( 2002; ). The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-κB. J Virol 76, 9664–9672.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.005678-0
Loading
/content/journal/jgv/10.1099/vir.0.005678-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error